Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Dermatofibrosarcoma × Magnetic Resonance Spectroscopy × Clear all

Sponsor

Conditions

Prostatic Neoplasms 23 Breast Neoplasms 23 Glioma 14 Carcinoma, Non-Small-Cell Lung 13 Neoplasm Metastasis 12 Lymphoma 12 Glioblastoma 11 Neuroblastoma 10 Lung Neoplasms 9 Brain Neoplasms 9 Medulloblastoma 8 Lymphoma, Non-Hodgkin 8 Carcinoma, Renal Cell 8 Neoplasms 7 Multiple Myeloma 7 Ependymoma 7 Wilms Tumor 6 Thyroid Neoplasms 6 Sarcoma 6 Rectal Neoplasms 6 Ovarian Neoplasms 6 Osteosarcoma 6 Fallopian Tube Neoplasms 6 Central Nervous System Neoplasms 6 Carcinoma, Hepatocellular 6 Uterine Cervical Neoplasms 5 Urinary Bladder Neoplasms 5 Thyroid Cancer, Papillary 5 Rhabdomyosarcoma 5 Rhabdoid Tumor 5

Interventions

Doxorubicin 4 pazopanib 2 Ifosfamide 2 saracatinib 1 sapanisertib 1 indolepropanol phosphate 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 MLN 8237 1 Imatinib Mesylate 1 HhAntag691 1 Gene Expression Profiling 1 Dexrazoxane 1 Blotting, Western 1 Albumin-Bound Paclitaxel 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡